These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8614278)

  • 1. Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand.
    Romero J; García-Palomero E; Lin SY; Ramos JA; Makriyannis A; Fernández-Ruiz JJ
    Life Sci; 1996; 58(15):1249-57. PubMed ID: 8614278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
    Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
    Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU; Lamb RJ; Lin S; Makriyannis A
    Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
    Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
    Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats.
    Järbe TU; DiPatrizio NV; Li C; Makriyannis A
    Behav Pharmacol; 2007 Nov; 18(7):673-80. PubMed ID: 17912052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
    Järbe TU; Lamb RJ; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats.
    Järbe TU; DiPatrizio NV; Li C; Makriyannis A
    Pharmacol Biochem Behav; 2003 Jul; 75(4):809-21. PubMed ID: 12957223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
    Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
    Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
    Lamb RJ; Järbe TU; Makriyannis A; Lin S; Goutopoulos A
    Eur J Pharmacol; 2000 Jun; 398(2):251-8. PubMed ID: 10854837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats.
    Järbe TU; Lamb RJ; Makriyannis A; Lin S; Goutopoulos A
    Psychopharmacology (Berl); 1998 Dec; 140(4):519-22. PubMed ID: 9888629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.
    de Miguel R; Romero J; Muñoz RM; García-Gil L; González S; Villanua MA; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
    Biochem Pharmacol; 1998 Nov; 56(10):1331-8. PubMed ID: 9825732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
    Anikwue R; Huffman JW; Martin ZL; Welch SP
    J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication.
    Järbe TU; Lamb RJ; Lin S; Makriyannis A
    Behav Pharmacol; 2000 Feb; 11(1):81-6. PubMed ID: 10821212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.
    Burkey RT; Nation JR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):195-202. PubMed ID: 9260067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
    Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.